Hera Biotech
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4725 College Park Ste 200, San Antonio, ...Phone Number
(210) 683-1069Website
www.herabiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Hera Biotech
Hera began operations in January of 2020 as a Delaware C Corporation with headquarters in San Antonio, TX. Heras initial goal is to commercialize the MetriDx, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. Hera Biotech, Inc. was formed to apply advances in biotechnology to address unmet needs in the field of womens health and specifically, in reproductive medicine.Explore more
Hera Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hera Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Hera Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Hera Biotech recently announced quarterly report
Funding: Get notified immidiatlly once Hera Biotech has new funding data
Website visits: Recent activity has been detected on your website
Check out if Hera Biotech is spiking on competitors!
Product Launch: Get notified when Hera Biotech launches new products
Click to see if Hera Biotech had a recent Job posting/layoffs
Check if Hera Biotech has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Hera Biotech
Recommended Actions
Find VP level buyers at Hera Biotech
Find 2 more new buyers
Compare Similar Companies to Hera Biotech
Compare insights from companies similar to Hera Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hera Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hera Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hera Biotech.
Hera Biotech financials insights
Gather financial insights about Hera Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$1.9M
2025
Debt
$797K
Hera Biotech Tech Stack
Most Recent Scoops
Funding
Funding
Person-Based
Funding
Funding
Hera Biotech News & Media
Hera Biotech to Make First Acquisition in the Endometriosis Diagnostic Market and Enter Into Strategic Partnership With Scailyte
SAN ANTONIO & BASEL, Switzerland--(BUSINESS WIRE)-- #ai--Hera Biotech announced today that it has reached an agreement to acquire the endometriosis diagnostic assets and associated IP of single-cell and AI-driven biomarker discovery company Scailyte, creating an important consolidation of the only two tissue-based diagnostic programs for endometriosis. Endometriosis is a highly prevalent and debilitating disease with severe health-economic impact that contributes to a large majority of female inHera Biotech Announces First Patient Enrolled in Endometriosis Diagnostic Study
SAN ANTONIO--(BUSINESS WIRE)--The first patient for the proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test by Hera Biotech has been enrolled at UTHealth Houston. Hera Biotech was formed to apply advances in biotechnology to address unmet needs in women’s healthcare. Its lead product is MetriDx™, a novel, non-surgical test that utilizes single-cell microfluidic analysis of proprietary biomarkers for the definitive, early diagnosis and staging of endometrioHera Biotech bags $1.9M for endometriosis diagnostic test - Labiotech
Hera Biotech has closed a $1.9M seed financing round to support commercialization of its non-surgical endometriosis diagnostic test, MetriDx.Hera Biotech Closes Oversubscribed $1.9 Million Seed Raise For Novel Diagnostic Test for Endometriosis
SAN ANTONIO--(BUSINESS WIRE)--Hera Biotech has closed a $1.9 million financing to support the commercialization of its non-surgical diagnostic test for endometriosis, MetriDx™.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hera Biotech
Sign Up For FreeTo access detailed company insights
Hera began operations in January of 2020 as a Delaware C Corporation with headquarters in San Antonio, TX. Heras initial goal is to commercialize the MetriDx, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. Hera Biotech, Inc. was formed to apply advances in biotechnology to address unmet needs in the field of w... Read More
